FDA

The Difference in Guanfacine Formulations for ADHD

By: Katharine Cimmino, Editor-in-Chief - Attention-deficit/hyperactivity disorder (ADHD) is the most common pediatric psychiatric disorder, and it affects the education,…

12 years ago

Recombinant Factor IX (Alprolix) Brings Hope for Hemophilia B Patients

By: Benedette Cuffari, BS Toxicology Candidate c/o 2015 - Hemophilia B is an inherited bleeding disorder that is caused by…

12 years ago

FDA Defends Generic Drug Labeling Plan

By: Nancy Simon, PharmD c/o 2016 - Last November, the Food and Drug Administration (FDA) submitted a proposal for a…

12 years ago

Off-Label Antidepressant Use in Pediatric Patients with Autism

By: Jacqueline Meaney, PharmD Candidate c/o 2015, University at Buffalo: School of Pharmacy and Pharmaceutical Sciences -- Psychotropic medications are…

12 years ago

The Silver Age of Antibiotics

By: Andrew Leong, Staff Writer -- This year, the FDA approved three new antibiotics to treat acute bacterial skin and…

12 years ago

Pradaxa® vs Warfarin

By: Kevin Lin, PharmD Candidate c/o 2015 -- The FDA recently completed an observational cohort study that compared Pradaxa® (dabigatran)…

12 years ago

FDA-Approved Afrezza: An Inhaled Alternative to Injectable Insulin?

By: Elissa Tam, PharmD Candidate c/o 2015 - Patients with Type 1 or Type 2 diabetes who cannot control their…

12 years ago

Combating Counterfeit Drugs

By: Azia Tariq, Staff Editor - With the sale of counterfeit drugs reaching an alarmingly higher rate than ever, The…

12 years ago

An Interview with an FDA Preceptor: Pharmacist’s Role at the FDA

By: Melissa Roy Co-Copy Editor [Graphics focused] - Our dedicated preceptor Kimberly Defronzo, RPh, MS, MBA is currently a Consumer…

12 years ago

Drug Shortages: Effects & Costs in the United States Healthcare System

By: Valentina DiGangi,PharmD Candidate c/o 2017, Brandon Hu, PharmD Candidate c/o 2018, Sang Hyo Kim, Staff Editor, Samantha Lau, PharmD…

12 years ago

Migraine Relief at the Push of a Button

By: Davidta Brown, Senior Staff Editor - A new therapeutic device has seemingly leapt from the pages of a science…

12 years ago

DIA: 50th Annual Meeting 2014

By: Melissa Roy, Co-Copy Editor [Graphics Focused] - DIA stands for Drug Information Association. It is an organization that strives…

12 years ago

Grastek®: FDA Approves New Sublingual Immunotherapy for Allergies

By: Kevin Lin, PharmD Candidate c/o 2015 - This April, the FDA approved three sublingual immunotherapies for pollen induced allergic…

12 years ago

The Importance of the Measles Vaccine: Should We Be Vaccinated?

By: Sherin Pathickal, PharmD Candidate c/o 2016 - The mandatory receipt of vaccinations as a preventive public health measure has…

12 years ago

Antipsychotic Use in the Elderly with Dementia

By: Ada Seldin, Staff Editor - The overuse of antipsychotics in the nursing home population for off-label indications continues to…

12 years ago

The Dangers of Intrathecal Baclofen

By: Ada Seldin, Staff Editor - Intrathecal baclofen (ITB) is indicated for the treatment of intractable spasticity caused by spinal…

12 years ago

New Considerations for Testosterone Therapy

By: Jenny Park PharmD Candidate c/o 2015 - Testosterone is a hormone essential to male development. However, treatment of testosterone…

12 years ago

Evzio™ – New Naloxone Auto-Injector For Opioid Overdose

By: Diana Gritsenko, PharmD Candidate c/o 2015 - Drug overdose is a serious problem in the United States.  In 2010,…

12 years ago

FDA Approves Drug Elosulfase Alfa (Vimizim™) for Mucopolysaccharidosis (MPS IVA)

By: Erica Dimitropoulos Co-Copy Editor [Content- Focused]  - On February 14, 2014, elosulfase alfa (Vimizim™) became an FDA-approved enzyme replacement therapy…

12 years ago

Brown-Bag Event

By: Hayeon Na, Co-Copy Editor (Content Focused) - On February 26th, 2014, pharmacists, clinical faculty, and pharmacy students from St.…

12 years ago

New Strides in Lupus Treatment

By: Daniel Mathan, PharmD Candidate c/o 2016, Anita Kachappilly, PharmD Candidate c/o 2016, & Amrita Singh, PharmD Candidate c/o 2015 -…

12 years ago

Riociguat (Adempas®) New Drug for Pulmonary Hypertension

By: Hayeon Na, Co-Copy Editor [Content-Focused] - On October 8th of 2013, Bayer’s new drug riociguat (Adempas®) was approved for…

12 years ago

The Surgeon General’s 2014 Report on Smoking

By: Ada Seldin, Staff Editor - Since the first release of the Surgeon General’s Report on smoking 50 years ago,…

12 years ago

Tasimelteon (Hetlioz®): First FDA Approved Pharmacologic Agent for Treatment of Non-24 in Completely Blind Individuals

By: Beatrisa Popovitz, Senior Staff Editor - On January 31st 2014, the FDA announced the release of a revolutionary new…

12 years ago

New Legislation Redefines Oversight for Compounding Pharmacies

By: Davidta Brown, Senior Staff Editor - As the world of healthcare and its provision evolves, laws which organize and…

12 years ago

Prior Experience and the Growth of the Biosimilars Market

By: Davidta Brown, Senior Staff Editor - In 21st century medicine, pharmaceuticals have come to include compounds derived through novel…

12 years ago

Dietary Supplements and Their Potential Dangers

By: Fatema Elias, Staff Writer - With the New Year and everyone committing to their New Year resolutions, more and…

12 years ago

To Defend the People

By: Davidta Brown, Senior Staff Editor - As the world’s largest market for pharmaceuticals, the United States receives many medications…

12 years ago

Long Term PPI Use Heightens Concern of Associated Health Consequences

By: Tamara Yunusova, Senior Staff Editor - Proton Pump Inhibitors (PPIs) are acid-reducing agents that have multiple uses in the…

12 years ago

Dr. Robert Mangione – From Student to Provost of St. John’s University

By: Katharine Cimmino, Editor-in-Chief and Melissa Roy, Co-Copy Editor [Graphics-Focused] - Dr. Mangione has been a prominent member here at…

12 years ago

Surviving APPE Rotations

By: Aleena Cherian, Co-Copy Editor [Graphics-Focused] and Jenny Prakash, PharmD Candidate c/o 2014 - Starting your rotations in 5th year…

12 years ago

New Alternative First Line Therapy for EGFR NSCLC

By: Jenny Park, PharmD Candidate c/o 2015 - On July 12, 2013, the FDA approved afatinib (GilotrifTM) as a new…

12 years ago

New Hepatitis C Drug Receives FDA Approval

By: Ada Seldin, Staff Editor - On November 22, 2013, simeprevir (Olysio®), a new agent to treat chronic hepatitis C,…

12 years ago

The Blunt Truth

By: Katharine Cimmino, Editor-in-Chief - Marijuana, also known as “grass,” “pot,” “joint,” “weed,” “reefer,” “hashish,” and “Mary Jane,” is a…

12 years ago

Newly Approved: Macitentan (Opsumit®)

By: Rebecca Gilene, PharmD Candidate c/o 2014, St. Louis College of Pharmacy - The FDA approved macitentan (Opsumit®) on October…

13 years ago

Possible Inhaled Option for Diabetics

By: Sang Hyo Kim, Staff Editor - Near the end of December, the pharmaceutical company, MannKind Corp, will submit their…

13 years ago

Ponatinib Taken Off the Market

By: Sherine Jaison, PharmD Candidate c/o 2015 -  The leukemia chemotherapy drug ponatinib (Iclusig) has just been taken off the…

13 years ago

Hospital Drug Shortages

By: Hamid Razaki, PharmD - Drug shortages seen across pharmacies in the United States continue to be an issue in…

13 years ago

Still a Long Road Ahead for New Hepatitis C Treatment

By: Ramya Mathew, PharmD Candidate c/o 2015 - Vertex Pharmaceuticals, an American biotechnology company based in Cambridge, Massachusetts, has been…

13 years ago

Zecuity(TM): Novel Treatment Option for Migraines

By: Arya Mathew, PharmD Candidate c/o 2014 -  About twelve percent of the U.S. population suffers from migraines, affecting adult…

13 years ago

Does Moxifloxacin Increase the Risk of Dysglycemia?

By: Nathan Trustman, PharmD Candidate c/o 2014, AMSCOP at LIU - The antibiotic class known as the fluoroquinolones is widely…

13 years ago

New Treatment for a Deficiency in Iron-Supplement Therapies

By: Davidta Brown, Staff Editor - For the estimated 7.5 million individuals in the United States living with iron deficiency…

13 years ago

New Drug to Treat HIV-1 Hits the Market

By: Ada Seldin, Staff Editor - On August 12,2013, a new weapon against HIV-1 infection was added to the existing…

13 years ago

After 15 Years, First New Recombinant Coagulation Factor IX (Rixubis) Gains Orphan Drug Approval

By: Tamara Yunusova, Senior Staff Editor - After a lengthy fifteen-year hiatus in recombinant drug approvals, FDA-approved Recombinant Coagulation Factor…

13 years ago

Ketoconazole No More

By: Hayeon Na, Co-Copy Editor [Content-Focused] - The Food and Drug Administration (FDA) announced on July 26th that oral dosage…

13 years ago

Canagliflozin (Invokana®): New Type 2 Diabetes Drug

By: Sang Hyo Kim, Staff Editor - On March 29th 2013, the U.S Food and Drug Administration approved canagliflozin (Invokana®),…

13 years ago

FDA’s New Warning: Acetaminophen Associated with Serious Skin Reactions

By: Andy Zhang, PharmD Candidate c/o 2015 - On August 1st, 2013, the U.S. Food and Drug Administration (FDA) released…

13 years ago

Olmesartan Medoxomil Label Revision

By: David Ong, PharmD Candidate c/o 2014 - Manipulating the renin-angiotensin system is one of the many ways drugs are…

13 years ago

HIV Test: Making a Difference

By: Sang Hyo Kim, Staff Editor - On June 27, 2013, the Centers for Disease Control and Prevention (CDC), AIDS.gov,…

13 years ago

Children, Codeine, and Cytochrome P-450

By Davidta Brown, Staff Editor - For post-operative pain treatment, few drugs are as trustworthy, as tried-and-true, as codeine. Prescriptive…

13 years ago